Incision-free prostate surgery: Verona as an international reference center
At the Azienda Ospedaliera Universitaria Integrata di Verona, urological surgery is evolving toward an increasingly micro-invasive model thanks to EchoLaser TPLA technology. The growing international interest — with specialists from multiple countries attending live...
EchoLaser TPLA in Turin: treating prostate cancer while traveling to the Caribbean through virtual reality
At Molinette Hospital in Turin, the university urology department led by Prof. Paolo Gontero has marked a turning point in prostate cancer surgery: EchoLaser TPLA (Transperineal Laser Ablation). This focal therapy, performed by Marco Oderda and Alessandro Marquis,...
EchoLaser and TPLA technique: successful procedures and international guests in Verona
On July 25th, 2025, at the Verona University Hospital (AOUI Verona), Professor Alessandro Antonelli and his team successfully performed three treatments for benign prostatic hyperplasia (BPH) and one focal therapy for prostate cancer using the EchoLaser system with...
EchoLaser TPLA at the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace (China)
Over 400 experts from 28 provinces attended the 12th National Academic Conference on Minimally Invasive Surgery in Aerospace. We are proud that, for the third consecutive year, our Chinese partner, Chenglai Pharmaceutical, was among the key players at this prestigious...
EchoLaser is now NMPA approved
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by...